 |
| |
| For Immediate Release |
| |
Bioterrorism
Multiplex Assay Presented at ASM Biodefense Research Meeting
WAUKESHA, WI (March 25, 2005) - Prodesse announced today that an abstract was
presented at the recent ASM Biodefense Research Meeting. The abstract is the
result of efforts by Prodesse and the Medical College of Wisconsin under a grant
from NIH to develop multiplex assays for detection of bioterror agents. The abstract
is entitled "Simultaneous Detection of CDC Category "A" DNA Bioterrorism
agents and Varicella in a single Multiplex PCR-EHA Assay." |
|
About Prodesse
Prodesse is a biotechnology company focused on developing analyte specific reagents
that can be used by CLIA certified laboratories to develop assays for detecting
infectious disease pathogens. The Company's reagents incorporate proprietary
technology that allows for the detection of multiple pathogens. Prodesse
currently offers nine different multiplex products covering 33 different
organisms. The company’s products can be used on a variety of detection
platforms. The Company sells its reagents to laboratories throughout the
US and the world, and also operates a CLIA certified laboratory for testing
services in the Midwest area. For more information about Prodesse and its
products, call 888-589-6974 or go to www.prodesse.com.
|
| |
| |
Press Contact:
Andy Shrago, Chief Marketing Officer
Prodesse, Inc.
Phone: (262) 446-0700
ashrago@prodesse.com |
| |
|
| |
|
